We also analyzed the ALKBH5 expression across gliomas with different WHO grades in the TCGA and CGGA cohorts, all the results indicated the highest expression of ALKBH5 in WHO IV gliomas (Fig. 4F–H). This evidence concerns the gene ALKBH5 and central nervous system cancer.